Skip to main content

Value and Use of Serologic Markers of Celiac Disease

  • Chapter
  • First Online:
Advances in Celiac Disease

Abstract

High efficient serological markers (SM) for celiac disease (CD) have evolved since the eighties thus completely modifying the approach to CD diagnosis. These celiac SM, i.e. tissue Transglutaminase (TG2), endomysial (EMA) and deamidated gliadin peptides (DGP) show different performance. Both IgA class TG2 (TGA-IgA) and EMA (EMA-IgA) display the highest accuracy. For EMA-IgA sensitivity in adults is slightly above 86% and the specificity close to 100%. In paediatric patients, sensitivity is ≥90%, and pooled specificity 98.2%. For TGA-IgA in the adult population sensitivity is above 95% and specificity in the range of 90%–96%, while in children sensitivity is around 90% and specificity around 95%. Measuring DGP antibodies, either IgA or IgG (DGPA-IgG/IgA) has a lower efficiency for CD diagnosis as compared to TGA and EMA, for all age groups. Contrary to other SM, DGPA-IgG perform better than IgA class tests. Only in IgA deficient individuals is an IgG based test indicated, preferably TGA-IgG or DGPA-IgG. If CD is suspected, measurement of total serum IgA and TGA-IgA is superior to other combinations and should be the initial step for initial testing at any age, while DGPA tests are not recommended because of their lower efficiency. In children and adolescents, due to their high accuracy, in absence of positive TGA/EMA CD diagnosis is unlikely, while in adults if the suspicion of CD is high, intestinal biopsy should be pursued even if SM are negative. Conversely children and adolescents with positive serology should be referred to a paediatric gastroenterologist to establish a firm diagnosis. On account of the high specificity of CD SM, patients with positive CD autoimmunity (TGA-IgA/EMA-IgA) but with mild histological changes (Marsh 0/I) should be followed carefully because of the risk of developing CD in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AGA:

Antigliadin antibodies

ARA:

Antireticulin antibodies

TGA-IgA:

IgA antibodies against type-2 (tissue) transglutaminase

TGA-IgG:

IgG antibodies against type-2 (tissue) transglutaminase

EMA-IgA:

IgA endomysial antibodies

DGP:

Deamidated gliadin peptides

ELISA:

Enzyme Immuno assay

IF:

Immunofluorescence

DGPA-IgG:

IgG Deamidated gliadin peptides antibodies

DGPA-IgA:

IgA Deamidated gliadin peptides antibodies

SM:

Serological marker

SBB:

Small bowel biopsy

TG2:

Tissue Transglutaminase

References

  1. GW Meeuwisse 1970 Diagnostic criteria in celiac disease Acta Paediatr Scand 59 909 911

    Google Scholar 

  2. JA Walker-Smith S Guandalini J Schmitz 1990 Revised criteria for diagnosis of coeliac disease Arch Dis Child 65 909 911

    Article  Google Scholar 

  3. S Husby S Koletzko IR Korponay-Szabó 2012 European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease J Pediatr Gastroenterol Nutr 54 136 160

    Article  PubMed  CAS  Google Scholar 

  4. A Rubio-Tapia ID Hill CP Kelly 2013 ACG clinical guidelines: diagnosis and management of celiac disease Am J Gastroenterol 108 656 676

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. S Husby JA Murray DA Katzka 2019 AGA clinical practice update on diagnosis and monitoring of celiac disease—changing utility of serology and histologic measures: expert review Gastroenterology 156 885 889

    Article  PubMed  Google Scholar 

  6. S Husby S Koletzko I Korponay-Szabó 2020 European Society paediatric gastroenterology, hepatology and nutrition guidelines for diagnosing coeliac disease 2020 J Pediatr Gastroenterol Nutr 70 141 156

    Article  PubMed  Google Scholar 

  7. CR Koninckx JP Giliams I Polanco 1984 IgA antigliadin antibodies in celiac and inflammatory bowel disease J Pediatr Gastroenterol Nutr 3 676 682

    Article  PubMed  CAS  Google Scholar 

  8. R Troncone A Ferguson 1991 Anti-gliadin antibodies J Pediatr Gastroenterol Nutr 12 150 158

    Article  PubMed  CAS  Google Scholar 

  9. M Mäki O Hällström T Vesikari 1984 Evaluation of a serum IgA-class reticulin antibody test for the detection of childhood celiac disease J Pediatr 105 901 905

    Article  PubMed  Google Scholar 

  10. A Lecea De C Ribes-Koninckx I Polanco 1996 Serological screening (antigliadin and antiendomysium antibodies) for non-overt coeliac disease in children of short stature Acta Paediatr Int J Paediatr Suppl 85 54 55

    Article  Google Scholar 

  11. E Grodzinsky G Jansson T Skogh 1995 Anti-endomysium and anti-gliadin antibodies as serological markers for coeliac disease in childhood: a clinical study to develop a practical routine Acta Pædiatrica 84 294 298

    Article  PubMed  CAS  Google Scholar 

  12. TM Rossi CH Albini V Kumar 1993 Incidence of celiac disease identified by the presence of serum endomysial antibodies in children with chronic diarrhea, short stature, or insulin-dependent diabetes mellitus J Pediatr 123 262 264

    Article  PubMed  CAS  Google Scholar 

  13. IR Korponay-Szabó JB Kovács A Czinner 1999 High prevalence of silent celiac disease in preschool children screened with IgA/IgG antiendomysium antibodies J Pediatr Gastroenterol Nutr 28 26 30

    Article  PubMed  Google Scholar 

  14. W Dieterich T Ehnis M Bauer 1997 Identification of tissue transglutaminase as the autoantigen of celiac disease Nat Med 3 797 801

    Article  PubMed  CAS  Google Scholar 

  15. CC Barker C Mitton G Jevon 2005 Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations? Pediatrics 115 1341 1346

    Article  PubMed  Google Scholar 

  16. I Dahlbom IR Korponay-Szabó JB Kovács 2010 Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase J Pediatr Gastroenterol Nutr 50 140 146

    Article  PubMed  CAS  Google Scholar 

  17. Ø Molberg SN Mcadam R Körner 1998 Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease Nat Med 4 713 717

    Article  PubMed  CAS  Google Scholar 

  18. E Schwertz F Kahlenberg U Sack 2004 Serologic assay based on gliadin-related nonapeptides as a highly sensitive and specific diagnostic aid in celiac disease Clin Chem 50 2370 2375

    Article  PubMed  CAS  Google Scholar 

  19. K Giersiepen M Lelgemann N Stuhldreher 2012 Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report J Pediatr Gastroenterol Nutr 54 229 241

    Article  PubMed  CAS  Google Scholar 

  20. MJ Gould H Brill MA Marcon 2019 In screening for celiac disease, deamidated gliadin rarely predicts disease when tissue transglutaminase is normal J Pediatr Gastroenterol Nutr 68 20 25

    Article  PubMed  Google Scholar 

  21. S Ferre-López C Ribes-Koninckx C Genzor 2004 Immunochromatographic sticks for tissue transglutaminase and antigliadin antibody screening in celiac disease Clin Gastroenterol Hepatol 2 480 484

    Article  PubMed  Google Scholar 

  22. P Singh A Arora TA Strand 2019 Diagnostic accuracy of point of care tests for diagnosing celiac disease: a systematic review and meta-analysis J Clin Gastroenterol 53 535 542

    Article  PubMed  CAS  Google Scholar 

  23. TP Chorzelski J Sulej H Tchorzewska 1983 IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease Ann N Y Acad Sci 420 325 334

    Article  PubMed  CAS  Google Scholar 

  24. Rostom A, Dubé C, Cranney A, et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology; 128. Epub ahead of print 2005. https://doi.org/10.1053/j.gastro.2005.02.028.

  25. IR Korponay-Szabó I Dahlbom K Laurila 2003 Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency Gut 52 1567 1571

    Article  PubMed  PubMed Central  Google Scholar 

  26. Rostom A, Dubé C, Cranney A, et al. Celiac disease. Evidence report/technology assessment (Summary) 2004; 1–6.

    Google Scholar 

  27. Mascart-Lemone F, Lambrechts A. Serology of coeliac disease: early diagnosis and therapeutic impact. In: Acta gastro-enterologica belgica;1995. p. 388–96.

    Google Scholar 

  28. A Picarelli M Tola Di L Sabbatella 2001 Identification of a new coeliac disease subgroup: antiendomysial and anti-transglutaminase antibodies of IgG class in the absence of selective IgA deficiency J Intern Med 249 181 188

    Article  PubMed  CAS  Google Scholar 

  29. N Tesei E Sugai H Vázquez 2003 Antibodies to human recombinant tissue transglutaminase may detect coeliac disease patients undiagnosed by endomysial antibodies Aliment Pharmacol Ther 17 1415 1423

    Article  PubMed  CAS  Google Scholar 

  30. V Baldas A Ventura T Not 2000 Development of a novel rapid non-invasive screening test for coeliac disease Gut 47 628 631

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. P Collin K Kaukinen H Vogelsang 2005 Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study Eur J Gastroenterol Hepatol 17 85 91

    Article  PubMed  CAS  Google Scholar 

  32. Werkstetter KJ, Korponay-Szabó IR, Popp A, et al. Accuracy in diagnosis of celiac disease without biopsies in clinical practice. Gastroenterology; 153. Epub ahead of print 2017. https://doi.org/10.1053/j.gastro.2017.06.002.

  33. M Roca E Donat N Marco-Maestud 2019 Efficacy study of anti-endomysium antibodies for celiac disease diagnosis: a retrospective study in a Spanish pediatric population J Clin Med 8 2179

    Article  PubMed Central  CAS  Google Scholar 

  34. K Kurppa T Räsänen P Collin 2012 Endomysial antibodies predict celiac disease irrespective of the titers or clinical presentation World J Gastroenterol 18 2511 2516

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  35. A Mubarak VM Wolters SAM Gerritsen 2011 A biopsy is not always necessary to diagnose celiac disease J Pediatr Gastroenterol Nutr 52 554 557

    Article  PubMed  Google Scholar 

  36. L Lorand RM Graham 2003 Transglutaminases: crosslinking enzymes with pleiotropic functions Nat Rev Mol Cell Biol 4 140 156

    Article  PubMed  CAS  Google Scholar 

  37. LM Sollid B Jabri 2011 Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disorders Curr Opin Immunol 23 732 738

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  38. D Sblattero F Florian E Azzoni 2002 The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments Eur J Biochem 269 5175 5181

    Article  PubMed  CAS  Google Scholar 

  39. M Bonamico C Tiberti A Picarelli 2001 Radioimmunoassay to detect antitransglutaminase autoantibodies is the most sensitive and specific screening method for celiac disease Am J Gastroenterol 96 1536 1540

    Article  PubMed  CAS  Google Scholar 

  40. P Vermeersch K Geboes G Mariën 2013 Defining thresholds of antibody levels improves diagnosis of celiac disease Clin Gastroenterol Hepatol 11 398 403

    Article  PubMed  Google Scholar 

  41. E Liu M Li F Bao 2005 Need for quantitative assessment of transglutaminase autoantibodies for celiac disease in screening-identified children J Pediatr 146 494 499

    Article  PubMed  CAS  Google Scholar 

  42. M Stern 2000 Comparative evaluation of serologic tests for celiac disease: a European initiative toward standardization J Pediatr Gastroenterol Nutr 31 513 519

    Article  PubMed  CAS  Google Scholar 

  43. M Li L Yu C Tiberti 2009 A report on the international transglutaminase autoantibody workshop for celiac disease Am J Gastroenterol 104 154 163

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  44. E Zintzaras AE Germenis 2006 Performance of antibodies against tissue transglutaminase for the diagnosis of celiac disease: meta-analysis Clin Vaccine Immunol 13 187 192

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  45. A Carroccio G Vitale L Prima Di 2002 Comparison of anti-transglutaminase ELISAs and an anti-endomysial antibody assay in the diagnosis of celiac disease: a prospective study Clin Chem 48 1546 1550

    Article  PubMed  CAS  Google Scholar 

  46. R Chou C Bougatsos I Blazina 2017 Screening for celiac disease: evidence report and systematic review for the US preventive services task force JAMA—J Am Med Assoc 317 1258 1268

    Article  Google Scholar 

  47. B Meensel Van M Hiele I Hoffman 2004 Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac disease Clin Chem 50 2125 2135

    Article  PubMed  CAS  Google Scholar 

  48. SL Vriezinga R Auricchio E Bravi 2014 Randomized feeding intervention in infants at high risk for celiac disease N Engl J Med 371 1304 1315

    Article  PubMed  CAS  Google Scholar 

  49. F Cataldo D Lio V Marino 2000 IgG1 antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency Gut 47 366 369

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  50. Villalta D, Alessio MG, Tampoia M, et al. Diagnostic accuracy of IgA anti-tissue transglutaminase antibody assays in celiac disease patients with selective IgA deficiency. In: Annals of the New York academy of sciences. Blackwell Publishing Inc.;2007. p. 212–20.

    Google Scholar 

  51. A Tursi G Brandimarte GM Giorgetti 2003 Prevalence of antitissue transglutaminase antibodies in different degrees of intestinal damage in celiac disease J Clin Gastroenterol 36 219 221

    Article  PubMed  CAS  Google Scholar 

  52. Diamanti A, Colistro F, Calce A, et al. Clinical value of immunoglobulin A antitransglutaminase assay in the diagnosis of celiac disease. Pediatrics; 118. Epub ahead of print December 2006. https://doi.org/10.1542/peds.2006-0604.

  53. Vivas S, Ruiz De Morales JG, Riestra S, et al. Duodenal biopsy may be avoided when high transglutaminase antibody titers are present. World J Gastroenterol 2009; 15: 4775–80.

    Google Scholar 

  54. MR Donaldson LS Book KM Leiferman 2008 Strongly positive tissue transglutaminase antibodies are associated with Marsh 3 histopathology in adult and pediatric celiac disease J Clin Gastroenterol 42 256 260

    Article  PubMed  CAS  Google Scholar 

  55. PG Hill GKT Holmes 2008 Coeliac disease: a biopsy is not always necessary for diagnosis Aliment Pharmacol Ther 27 572 577

    Article  PubMed  CAS  Google Scholar 

  56. S Castellaneta E Piccinno M Oliva 2015 High rate of spontaneous normalization of celiac serology in a cohort of 446 children with type 1 diabetes: a prospective study Diabetes Care 38 760 766

    Article  PubMed  CAS  Google Scholar 

  57. F Ferrara S Quaglia I Caputo 2010 Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases Clin Exp Immunol 159 217 223

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  58. HJ Freeman 2004 Strongly positive tissue transglutaminase antibody assays without celiac disease Can J Gastroenterol 18 25 28

    Article  PubMed  Google Scholar 

  59. Garcia-Peris M, Donat Aliaga E, Roca Llorens M, et al. Anti-tissue transglutaminase antibodies not related to gluten intake. An Pediatr. Epub ahead of print 2018. https://doi.org/10.1016/j.anpedi.2018.01.013.

  60. Wolf J, Haendel N, Remmler J, et al. Hemolysis and IgA-antibodies against tissue transglutaminase: When are antibody test results no longer reliable? J Clin Lab Anal; 32. Epub ahead of print 1 May 2018. https://doi.org/10.1002/jcla.22360.

  61. ID Hill MH Dirks GS Liptak 2005 Guideline for the diagnosis and treatment of celiac disease in children: Recommendations of the North American Society for pediatric gastroenterology, hepatology and nutrition J Pediatr Gastroenterol Nutr 40 1 19

    Article  PubMed  Google Scholar 

  62. D Agardh 2007 Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease Clin Gastroenterol Hepatol 5 1276 1281

    Article  PubMed  CAS  Google Scholar 

  63. E Sugai H Vázquez F Nachman 2006 Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease Clin Gastroenterol Hepatol 4 1112 1117

    Article  PubMed  CAS  Google Scholar 

  64. Brusca I. Overview of biomarkers for diagnosis and monitoring of celiac disease. In: Adv Clin Chem. Academic Press Inc.;2015. p. 1–55.

    Google Scholar 

  65. I Brusca A Carroccio E Tonutti 2012 The old and new tests for celiac disease: which is the best test combination to diagnose celiac disease in pediatric patients? Clin Chem Lab Med 50 111 117

    Article  CAS  Google Scholar 

  66. D Basso G Guariso P Fogar 2009 Antibodies against synthetic deamidated gliadin peptides for celiac disease diagnosis and follow-up in children Clin Chem 55 150 157

    Article  PubMed  CAS  Google Scholar 

  67. S Simell A Kupila S Hoppu 2005 Natural history of transglutaminase autoantibodies and mucosal changes in children carrying HLA-conferred celiac disease susceptibility Scand J Gastroenterol 40 1182 1191

    Article  PubMed  CAS  Google Scholar 

  68. O Olen AH Gudjónsdóttir L Browaldh 2012 Antibodies against deamidated gliadin peptides and tissue transglutaminase for diagnosis of pediatric celiac disease J Pediatr Gastroenterol Nutr 55 695 700

    Article  PubMed  CAS  Google Scholar 

  69. E Liu M Li L Emery 2007 Natural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease J Pediatr Gastroenterol Nutr 45 293 300

    Article  PubMed  CAS  Google Scholar 

  70. K Kurppa K Lindfors P Collin 2011 Antibodies against deamidated gliadin peptides in early-stage celiac disease J Clin Gastroenterol 45 673 678

    Article  PubMed  CAS  Google Scholar 

  71. L Mozo J Gómez E Escanlar 2012 Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients J Pediatr Gastroenterol Nutr 55 50 55

    Article  PubMed  CAS  Google Scholar 

  72. LCB Baviera ED Aliaga L Ortigosa 2007 Celiac disease screening by immunochromatographic visual assays: results of a multicenter study J Pediatr Gastroenterol Nutr 45 546 550

    Article  PubMed  Google Scholar 

  73. IR Korponay-Szabó K Szabados J Pusztai 2007 Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study Br Med J 335 1244 1247

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Ribes-Koninckx .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Ribes-Koninckx, C., Roca, M., Donat, E. (2022). Value and Use of Serologic Markers of Celiac Disease. In: Amil-Dias, J., Polanco, I. (eds) Advances in Celiac Disease . Springer, Cham. https://doi.org/10.1007/978-3-030-82401-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-82401-3_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-82400-6

  • Online ISBN: 978-3-030-82401-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics